Natural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus

15Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

There is a close relationship between Alzheimer's disease (AD) and diabetes mellitus (DM), and the link between the two is often referred to as type 3 diabetes mellitus (T3DM). Many natural bioactive compounds have shown the potential to treat AD and diabetes. We mainly review the polyphenols represented by resveratrol (RES) and proanthocyanidins (PCs) and alkaloids represented by berberine (BBR) and Dendrobium nobile Lindl. alkaloids (DNLA) from the perspective of T3DM to review the neuroprotective effects and molecular mechanisms of natural compounds in AD.

Cite

CITATION STYLE

APA

Huang, J., Huang, N., Mao, Q., Shi, J., & Qiu, Y. (2023). Natural bioactive compounds in Alzheimer’s disease: From the perspective of type 3 diabetes mellitus. Frontiers in Aging Neuroscience. Frontiers Media S.A. https://doi.org/10.3389/fnagi.2023.1130253

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free